Navigation Links
Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
Date:12/7/2007

SANTA MONICA, Calif., Dec. 7 /PRNewswire-USNewswire/ -- California's stem cell agency made the correct decision today when it announced it was rejecting 10 applications for research grants because of apparent conflict of interest violations in California's $6 billion stem cell program, the Foundation for Taxpayer and Consumer Rights (FTCR) said.

The non-partisan, non-profit consumer advocacy organization added that to completely resolve the matter, the stem cell agency must identify the universities and stem cell board members involved.

"The only way to fix this is complete transparency," said John M. Simpson, FTCR's Stem Cell Project director. "People have a right to know which board members still don't understand conflict of interest rules."

The latest improprieties were revealed by the San Francisco Chronicle and came in the wake of the revelation that John Reed, Burnham Institute president and stem cell board member, had lobbied to reverse the rejection of a grant to his institution. Read the Chronicle story here: http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/12/07/BAOTTQ0JO.DTL&f eed=rss.bayarea

"It's simple: stem cell board members cannot take part in any way in grants to their institutions," said John M. Simpson, FTCR's Stem Cell Project Director. "The board is not some old-boys' club for the benefit of the state's universities. They are public officials and stewards of the public interest. Perhaps a few of these deans need to enroll in Ethics 101 at their universities and get the basics down."

The new violations of stem cell board ethics rules came when some university deans who also serve on the stem cell board wrote letters supporting applications for research grants. The grants in question could total $3 million each over five years. During its meeting in Los Angeles next week, the stem cell board plans to award up to $85 million for the grants which are aimed at faculty members just starting their independent research careers.

The Chronicle said applications from UC San Diego, UC San Francisco, UC Los Angeles and the University of Southern California were affected.

"There could be more or the Chronicle could be wrong," said Simpson. "The only fair thing is for the stem cell agency to lay everything out in the open. We don't need to name the scientists, but the public has a right to know what institutions and board members made mistakes."

FTCR has filed a complaint with the Fair Political Practices Commission (FPPC) about the Reed incident and called for both him and stem cell chairman Robert Klein to resign. Stem cell board members Jeff Sheehy and David Serrano Sewell have also called for Reed to step down from the board. State Controller John Chiang has announced plans to audit the agency and asked the FPPC to investigate.

The latest improprieties, though serious, are not as egregious as the Reed affair, FTCR said. The agency's call for applications asked for a letter of support either from the dean or department chairman. "Board members have signed conflict of interest rules and clearly should know what's right and what they can do," said Simpson. "However, this is not the same flagrant violation as actively lobbying to overturn a decision. Throwing out the tainted applications should be an adequate punishment."

FTCR also said that the stem cell committee should discuss at its meeting Wednesday what penalties are right for violations of its rules by board members. "They've got all these supposed rules that Chairman Klein likes to call 'the gold-standard,' but they are absolutely meaningless unless there are consequences when they are broken," said Simpson.

Proposition 71, passed by 59 percent of Californians in 2004, created an oversight board fraught with potential conflicts of interest. "Most of the people handing out the money are the very same people from the institutions that get the money," said Simpson. "That means the conflict rules in place must be strictly adhered to and there must be consequences when they are violated. 'Golly, we meant well and will do better next time' simply does not cut it."

FTCR's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will award $3 billion in grants over a decade. Bond financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
2. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
3. LifeNet Health Establishes The Skin & Wound Allograft Institute
4. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
5. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
6. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
7. The Integrated Benefits Institute Offers Largest Benchmarking Database in U.S. Spanning Disability and Workers Compensation Programs
8. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
9. Bullying Prevention Institute Designed to Empower Change in Schools
10. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
11. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
(Date:4/24/2017)... ... ... Emmanuel College is introducing enhancements to its RN-to-BSN Degree ... fall of 2017, Emmanuel’s program will allow registered nurses (RN)s to earn a Bachelor ... as little as $14,528. These changes will enable nurses to complete their degree in ...
(Date:4/24/2017)... ... , ... Michael Vick announced his retirement earlier this year from the NFL ... one pick in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro ... career rushing yards by a quarterback (6,109) and the most rushing yards by a ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
Breaking Medicine Technology: